相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials
Alessandro Mantovani et al.
METABOLITES (2021)
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
Philip N. Newsome et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
CB1Rs in VMH neurons regulate glucose homeostasis but not body weight
Carlos M. Castorena et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2021)
Space-time logic of liver gene expression at sub-lobular scale
Colas Droin et al.
NATURE METABOLISM (2021)
Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
Gordon Smith et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Cannabinoids and the expanded endocannabinoid system in neurological disorders
Luigia Cristino et al.
NATURE REVIEWS NEUROLOGY (2020)
Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis
Sergio Quesada-Vazquez et al.
CELLS (2020)
Hepatocyte Deletion of Triglyceride-Synthesis Enzyme Acyl CoA: Diacylglycerol Acyltransferase 2 Reduces Steatosis Without Increasing Inflammation or Fibrosis in Mice
Nina L. Gluchowski et al.
HEPATOLOGY (2019)
Comprehensive Integration of Single-Cell Data
Tim Stuart et al.
CELL (2019)
A human liver cell atlas reveals heterogeneity and epithelial progenitors
Nadim Aizarani et al.
NATURE (2019)
Cannabinoid-1 Receptor Antagonism Improves Glycemic Control and Increases Energy Expenditure Through Sirtuin-1/Mechanistic Target of Rapamycin Complex 2 and 5′Adenosine Monophosphate-Activated Protein Kinase Signaling
Jie Liu et al.
HEPATOLOGY (2019)
Dimensionality reduction for visualizing single-cell data using UMAP
Etienne Becht et al.
NATURE BIOTECHNOLOGY (2019)
Metabolic Targets in Nonalcoholic Fatty Liver Disease
William P. Esler et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice
Albert G. Linden et al.
JOURNAL OF LIPID RESEARCH (2018)
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Andrew Butler et al.
NATURE BIOTECHNOLOGY (2018)
GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease
Rohit Loomba et al.
GASTROENTEROLOGY (2018)
Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations
Sonya A. MacParland et al.
NATURE COMMUNICATIONS (2018)
Single-cell spatial reconstruction reveals global division of labour in the mammalian liver
Keren Bahar Halpern et al.
NATURE (2017)
Mechanisms of hepatic stellate cell activation
Takuma Tsuchida et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
Brandon J. Perumpail et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Metabolic zonation of the liver: The oxygen gradient revisited
Thomas Kietzmann
REDOX BIOLOGY (2017)
Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation
Chai-Wan Kim et al.
CELL METABOLISM (2017)
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
Eduardo Vilar-Gomez et al.
GASTROENTEROLOGY (2015)
Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients
Guillaume Lassailly et al.
GASTROENTEROLOGY (2015)
Scap is required for sterol synthesis and crypt growth in intestinal mucosa
Matthew R. McFarlane et al.
JOURNAL OF LIPID RESEARCH (2015)
High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers
Ingmar Mederacke et al.
NATURE PROTOCOLS (2015)
Cannabinoid signaling and liver therapeutics
Ariane Mallat et al.
JOURNAL OF HEPATOLOGY (2013)
Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology
Ingmar Mederacke et al.
NATURE COMMUNICATIONS (2013)
The Scap/SREBP Pathway Is Essential for Developing Diabetic Fatty Liver and Carbohydrate-Induced Hypertriglyceridemia in Animals
Young-Ah Moon et al.
CELL METABOLISM (2012)
Hepatic Cannabinoid Receptor-1 Mediates Diet-Induced Insulin Resistance via Inhibition of Insulin Signaling and Clearance in Mice
Jie Liu et al.
GASTROENTEROLOGY (2012)
Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl4-induced advanced cirrhosis
Ferdinando A. Giannone et al.
LABORATORY INVESTIGATION (2012)
Endocannabinoids in Liver Disease
Joseph Tam et al.
HEPATOLOGY (2011)
An overview of the metabolic effects of rimonabant in randomized controlled trials: potential for other cannabinoid 1 receptor blockers in obesity
F. D. Christopoulou et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2011)
Human Fatty Liver Disease: Old Questions and New Insights
Jonathan C. Cohen et al.
SCIENCE (2011)
CB1 Signaling in Forebrain and Sympathetic Neurons Is a Key Determinant of Endocannabinoid Actions on Energy Balance
Carmelo Quarta et al.
CELL METABOLISM (2010)
Enhancement in liver SREBP-1c/PPAR-α ratio and steatosis in obese patients: Correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion
Paulina Pettinelli et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
A critical review of the cannabinoid receptor as a drug target for obesity management
F. Akbas et al.
OBESITY REVIEWS (2009)
Endocannabinoid system in food intake and metabolic regulation
David Jesudason et al.
CURRENT OPINION IN LIPIDOLOGY (2008)
Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice
Douglas Osei-Hyiaman et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis
Fatima Teixeira-Clerc et al.
NATURE MEDICINE (2006)
Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis
H Dhillon et al.
NEURON (2006)
Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia
JP Despres et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
D Osei-Hyiaman et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
JD Browning et al.
HEPATOLOGY (2004)
Molecular mediators of hepatic steatosis and liver injury
JD Browning et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Immunohistochemical localization of cannabinoid CB1 receptor in inhibitory interneurons in the cerebellum
JC Ashton et al.
CEREBELLUM (2004)
The endogenous cannabinoid system controls extinction of aversive memories
G Marsicano et al.
NATURE (2002)
分享论文
